Formal neuropsychological testing revealed cognitive deficits in the majority of CACNA1A patients (19 out of 22 versus 5 out of 14 in the GAA-FGF14 group; p < 0.01 at Fisher’s exact test). Here, FGF14 is linked to Cognitive impairment.